Semin Liver Dis 2010; 30: 075-086DOI: 10.1055/s-0030-1247134ABSTRACTIdentification of novel oncogenes and tumor suppressors in hepatocellular carcinoma (HCC) is challenging, both because of the tumor complexity and the difficulty in integrating the very large amount of data provided by different approaches. The authors consider it very important to identify new pathways of carcinogenesis and to understand the mechanisms underlying their alteration in tumors to design personalized treatments for HCC. In this review, the main global genomic approaches are considered in detail. The authors present a catalog of the most important oncogenes and tumor suppressor genes that have been found to be mutated in HCC and hepatocellular adenoma. They also review the results provided by transcriptome and …

Further information:

Article source

Related posts:

1. Mouse Models of Hepatocellular Carcinoma
2. Hepatocellular Carcinoma and Hepatic Adenocarcinosarcoma in a Patient with Hepatitis B Virus-Related Cirrhosis
3. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
4. Pathology of Early Hepatocellular Carcinoma: Conventional and Molecular Diagnosis
5. Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation